Vir Biotechnology
VIR
11.52
-0.08
-0.69%
Vir Biotechnology
US · VIR
#2824 by market cap
Listed 2019
11.52
-0.08
-0.69%
Live - 5344 symbols - heartbeat 348s ago
· 2026-10-08 08:30
Pre-market
11.85
+2.86%
After-hours
11.52
0.00%
Overnight
11.64
+1.04%
- Market cap
- 1.95B
- P/E (TTM)i
- -6.51
- P/Bi
- 1.98
- EPSi
- -3.16
- Div yieldi
- 0.00%
- 52W posi
- 94%
Reader sentiment
Are you bullish or bearish on VIR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.8 percentage points.
Institutional ownership
- Held by institutions
- 88.48% -0.85pp
- Institutions
- 286 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund48.09%
VC/PE Fund20.64%
Hedge Fund13.88%
Individual/Insider4.23%
Public Company3.32%
Private Company1.01%
Insurance Company0.80%
Government Pension Fund0.70%
Other7.30%
Top holders as of 2026-06-30
BlackRock
12.22% · 20.68M sh
Arch Venture Partners, L.P.
7.50% · 12.69M sh
Vanguard Portfolio Management, LLC
6.79% · 11.50M sh
SB Investment Advisers (UK) Limited
6.47% · 10.95M sh
State Street Global Advisors
5.89% · 9.96M sh
GSK Equity Investments, Limited
5.05% · 8.55M sh
Vanguard Capital Management, LLC
4.27% · 7.23M sh
Point72 Asset Management, L.P.
3.35% · 5.67M sh
George Scangos
2.23% · 3.78M sh
Geode Capital Management, LLC
1.98% · 3.35M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 18 buys · 31 sells
| Name | Role | Stake |
|---|---|---|
| George Scangos | Director | 2.23% |
| Vicki Sato | Independent Chairperson | 0.63% |
| Marianne De Backer | Chief Executive Officer | 0.59% |
| Robert Taylor Nelsen | Independent Director | 0.37% |
| Ann Hanly | Executive VP & Chief Technology Officer | 0.04% |
| Brent Sabatini | Senior VP, Principal Accounting Officer & Chief Accounting Officer | 0.04% |
| Robert J. More | Independent Director | 0.02% |
| Charles Sigal | Independent Director | 0.01% |
| Jeffrey Hatfield | Independent Director | 0.01% |
| Jason O'Byrne | -- | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-16 | Jason O'Byrne | -- | Intent to Sell (Form 144) | -19,357 | $11.00 |
| 2026-09-08 | Jason O'Byrne | -- | Intent to Sell (Form 144) | -28,333 | $11.13 |
| 2026-08-24 | Jason O'Byrne | -- | Intent to Sell (Form 144) | -23,148 | $10.48 |
| 2026-08-23 | Jason O'Byrne | -- | Intent to Sell (Form 144) | -14,352 | $9.90 |
| 2026-08-20 | Jason O'Byrne | -- | Intent to Sell (Form 144) | -25,000 | $9.81 |
| 2026-08-10 | Alta Partners LP | -- | Other Acquisition | +8,000 | -- |
| 2026-08-10 | Robert J. More | Independent Director | Other Disposition | -8,000 | -- |
| 2026-06-28 | Sona Saira Ramasastry | Independent Director | Intent to Sell (Form 144) | -16,000 | $10.32 |
| 2026-06-08 | Timothy Coughlin | Director | Other Acquisition | +16,000 | -- |
| 2026-06-08 | Timothy Coughlin | Director | Other Derivative Acquisition | +16,000 | $8.51 |
| 2026-06-08 | Timothy Coughlin | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-05-31 | Janet Napolitano | Independent Director | Automatic Disposition | -3,200 | $9.45 |
| 2026-05-31 | Brent Sabatini | Senior VP, Principal Accounting Officer & Chief Accounting Officer | Automatic Disposition | -379 | $9.45 |
| 2026-05-26 | Robert J. More | Independent Director | Other Acquisition | +8,000 | -- |
| 2026-05-26 | Robert J. More | Independent Director | Other Derivative Acquisition | +16,000 | $9.10 |
| 2026-05-26 | Norbert Bischofberger | Independent Director | Other Acquisition | +8,000 | -- |
| 2026-05-26 | Norbert Bischofberger | Independent Director | Other Derivative Acquisition | +16,000 | $9.10 |
| 2026-05-26 | Charles Sigal | Independent Director | Other Acquisition | +8,000 | -- |
| 2026-05-26 | Charles Sigal | Independent Director | Other Derivative Acquisition | +16,000 | $9.10 |
| 2026-05-26 | Janet Napolitano | Independent Director | Other Acquisition | +8,000 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:30:00 · For reference only, not investment advice and not tailored to your situation.